|
Quality of life outcomes after neobladder and ileal conduit following cystectomy for bladder cancer using a validated bladder-specific instrument: A prospective multi-institutional study. |
|
|
Honoraria - Astellas Pharma; Ipsen; Janssen; Sanofi Pasteur |
Research Funding - Astellas Pharma (Inst); Ferring (Inst) |
Travel, Accommodations, Expenses - Ipsen; Janssen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Myriad Genetics; Sanofi Pasteur |
Travel, Accommodations, Expenses - Ipsen; Janssen |
|
|
No Relationships to Disclose |
|
|
Honoraria - Ipsen; Janssen; Sanofi; Takeda |
Consulting or Advisory Role - Janssen; Sanofi |
Research Funding - Ferring (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Ipsen; Janssen |
|
|
Honoraria - Sanofi Pasteur |
Consulting or Advisory Role - Ipsen; Sanofi Pasteur |